Günter Höglinger
Günter Höglinger
Ludwig-Maximilians-University Hospital, Munich
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ...
Movement disorders 32 (6), 853-864, 2017
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
GU Höglinger, P Rizk, MP Muriel, C Duyckaerts, WH Oertel, I Caille, ...
Nature neuroscience 7 (7), 726-735, 2004
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ...
Nature genetics 43 (7), 699-705, 2011
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
GU Höglinger, J Féger, A Prigent, PP Michel, K Parain, P Champy, ...
Journal of neurochemistry 84 (3), 491-502, 2003
Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors
B Nait-Oumesmar, N Picard-Riera, C Kerninon, L Decker, D Seilhean, ...
Proceedings of the National Academy of Sciences 104 (11), 4694-4699, 2007
Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation
K Ridder, S Keller, M Dams, AK Rupp, J Schlaudraff, D Del Turco, ...
PLoS biology 12 (6), e1001874, 2014
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases
G Respondek, M Stamelou, C Kurz, LW Ferguson, A Rajput, WZ Chiu, ...
Movement Disorders 29 (14), 1758-1766, 2014
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
AL Boxer, JT Yu, LI Golbe, I Litvan, AE Lang, GU Höglinger
The Lancet Neurology 16 (7), 552-563, 2017
Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease
GU Höglinger, G Carrard, PP Michel, F Medja, A Lombès, M Ruberg, ...
Journal of neurochemistry 86 (5), 1297-1307, 2003
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
GU Höglinger, JJ Breunig, C Depboylu, C Rouaux, PP Michel, ...
Proceedings of the National Academy of Sciences 104 (9), 3585-3590, 2007
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ...
Movement Disorders 29 (4), 470-478, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ...
The Lancet Neurology 13 (7), 676-685, 2014
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe
P Champy, GU Höglinger, J Féger, C Gleye, R Hocquemiller, A Laurens, ...
Journal of neurochemistry 88 (1), 63-69, 2004
The movement disorder society criteria for the diagnosis of multiple system atrophy
GK Wenning, I Stankovic, L Vignatelli, A Fanciulli, G Calandra‐Buonaura, ...
Movement Disorders 37 (6), 1131-1148, 2022
The differential diagnosis and treatment of atypical parkinsonism
J Levin, A Kurz, T Arzberger, A Giese, GU Höglinger
Deutsches Ärzteblatt International 113 (5), 61, 2016
Dopamine and adult neurogenesis
A Borta, GU Höglinger
Journal of neurochemistry 100 (3), 587-595, 2007
Distribution patterns of tau pathology in progressive supranuclear palsy
GG Kovacs, MJ Lukic, DJ Irwin, T Arzberger, G Respondek, EB Lee, ...
Acta neuropathologica 140, 99-119, 2020
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
F Ros-Bernal, S Hunot, MT Herrero, S Parnadeau, JC Corvol, L Lu, ...
Proceedings of the National Academy of Sciences 108 (16), 6632-6637, 2011
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
GU Höglinger, A Lannuzel, ME Khondiker, PP Michel, C Duyckaerts, ...
Journal of neurochemistry 95 (4), 930-939, 2005
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20